Evidence map›Paper›PMID 35925789›Full record

ArticleTissue engineering. Part C, Methods2022

Robust, Automated Analysis of Electrophysiology in Induced Pluripotent Stem Cell-Derived Micro-Heart Muscle for Drug Toxicity.

Kasoorelope Oguntuyo, David Schuftan, Jingxuan Guo, Daniel Simmons, Druv Bhagavan, Jonathan D Moreno, Po Wei Kang, Evan Miller, Jonathan R Silva, Nathaniel Huebsch

Open access · greenAbstract read
In one paragraph

Article in Tissue engineering. Part C, Methods, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Dynamic control of contractile resistance to iPSC-derived micro-heart muscle arrays.Journal of biomedical materials research. Part A · 2024
    Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Kasoorelope OguntuyoDepartment of Biomedical Engineering, Washington University in St. Louis, St. Louis, Missouri, USA.ORCID 0000-0001-8479-8096
David SchuftanDepartment of Biomedical Engineering, Washington University in St. Louis, St. Louis, Missouri, USA.
Jingxuan GuoDepartment of Mechanical Engineering and Materials Science, Washington University in St. Louis, St. Louis, Missouri, USA.ORCID 0000-0002-3344-2839
Daniel SimmonsDepartment of Biomedical Engineering, Washington University in St. Louis, St. Louis, Missouri, USA.
Druv BhagavanDepartment of Biomedical Engineering, Washington University in St. Louis, St. Louis, Missouri, USA.ORCID 0000-0002-1396-0532
Jonathan D MorenoDivision of Cardiology, Department of Medicine, Washington University in St. Louis, St. Louis, Missouri, USA.
Po Wei KangDepartment of Biomedical Engineering, Washington University in St. Louis, St. Louis, Missouri, USA.ORCID 0000-0002-5933-545X
Evan MillerDepartment of Chemistry, University of California, Berkeley, Berkeley, California, USA.ORCID 0000-0002-6556-7679
Jonathan R SilvaDepartment of Biomedical Engineering, Washington University in St. Louis, St. Louis, Missouri, USA.ORCID 0000-0002-3696-3955
Nathaniel HuebschDepartment of Biomedical Engineering, Washington University in St. Louis, St. Louis, Missouri, USA.ORCID 0000-0002-3329-0214
Washington University in St. Louis · USUniversity of California, Berkeley · US

Funding

NATIONAL RESEARCH SERVICE AWARD-MEDICAL SCIENTISTT32GM007200 · NIGMS · WASHINGTON UNIVERSITY · PI YOKOYAMA, WAYNE M. · 1985 to 2024
$59.8M
Personalizing Class I anti-Arrhythmic Drug TherapyR01HL148803 · NHLBI · WASHINGTON UNIVERSITY · PI SILVA, JONATHAN R · 2020 to 2024
$3.2M
Biomaterial Platforms to Model the Role of Mechanical Overload in MYBPC3-Linked Hypertrophic CardiomyopathyR01HL159094 · NHLBI · WASHINGTON UNIVERSITY · PI HUEBSCH, NATHANIEL · 2021 to 2025
$2.0M
3-Dimensional virtual ventricles to design precision therapies in hypertrophic cardiomyopathyK08HL153794 · NHLBI · WASHINGTON UNIVERSITY · PI MORENO, JONATHAN · 2021 to 2022
$286k
Calmodulin Regulation of KCNQ1 Potassium ChannelsF30HL151042 · NHLBI · WASHINGTON UNIVERSITY · PI KANG, PO WEI · 2020 to 2022
$136k
NHLBI NIH HHS F30 HL151042NHLBI NIH HHS K08 HL153794NHLBI NIH HHS R01 HL148803NHLBI NIH HHS R01 HL159094NIGMS NIH HHS T32 GM007200
6 · The paper itself

Abstract

Drugs are often removed from clinical trials or market progression owing to their unforeseen effects on cardiac action potential and calcium handling. Induced pluripotent stem cell-derived cardiomyocytes and tissues fabricated from these cells are promising as screening tools for early identification of these potential cardiac liabilities. In this study, we describe an automated, open-source MATLAB-based analysis software for calculating cardiac action potentials and calcium transients from fluorescent reporters. We first identified the most robust manner in which to automatically identify the initiation point for action potentials and calcium transients in a user-independent manner, and used this approach to quantify the duration and morphology of these signals. We then demonstrate the software by assessing changes to action potentials and calcium transients in our micro-heart muscles after exposure to hydroxychloroquine, an antimalarial drug with known cardiac liability. Consistent with clinical observations, our system predicted mild action potential prolongation. However, we also observed marked calcium transient suppression, highlighting the advantage of testing multiple physiologic readouts in cardiomyocytes rather than relying on heterologous overexpression of single channels such as the human

Indexed as

AntimalarialsDrug-Related Side Effects and Adverse ReactionsInduced Pluripotent Stem CellsCalciumElectrophysiologyEthersHumansHydroxychloroquineMyocytes, CardiacAntimalarialsCalciumEthersHydroxychloroquinecardiac tissueelectrophysiologyimagingIPS cells

Identifiers

PMID35925789
PMCPMC9527045
OpenAlexW4281767109

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.